Antibody–Drug Conjugates for the Treatment of Breast Cancer
There is a growing number of ADC drugs in development in breast cancer, with no shortage of novel study designs (Table 1.). If these agents continue to show promising activity in early studies, ADC drugs are expected to further transform the breast cancer treatment landscape in the coming years.
Like this book? You can publish your book online for free in a few
minutes!